Tg Therapeutics (TGTX) Cash from Operations (QoQ) (2011 - 2026)
Tg Therapeutics (TGTX) Cash from Operations (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -191.02% |
| Dec 31, 2025 | 184.91% |
| Sep 30, 2025 | -411.36% |
| Jun 30, 2025 | 125.90% |
| Mar 31, 2025 | -11.99% |
| Dec 31, 2024 | -110.09% |
| Sep 30, 2024 | -320.47% |
| Jun 30, 2024 | 167.45% |
| Mar 31, 2024 | 37.87% |
| Dec 31, 2023 | -115.78% |
| Sep 30, 2023 | 299.27% |
| Jun 30, 2023 | 29.88% |
| Mar 31, 2023 | -150.95% |
| Dec 31, 2022 | 30.80% |
| Sep 30, 2022 | 29.77% |
| Jun 30, 2022 | 28.50% |
| Mar 31, 2022 | 20.96% |
| Dec 31, 2021 | -29.33% |
| Sep 30, 2021 | -11.69% |
| Jun 30, 2021 | 26.04% |